Comparison of rectal with oral mesalazine in the treatment of Ulcerative Proctitis (CORRECT Study)
Not Applicable
- Conditions
- lcerative colitis
- Registration Number
- JPRN-UMIN000010340
- Lead Sponsor
- Saitama Medical Center, Saitama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients started to be treated with rectal 5-ASA and/or rectal steroids within 30 days before entry 2. Patients started to be treated with oral steroids within 14 days before entry 3. Patients with pregnancy or with the possibility of pregnancy 4. Patients with allergy of mesalazine and/or salicylic acid 5. Patients who have experienced severe side effects of mesalazine. 6. Patients with liver and/or renal dysfunctuon 7. Patinets with malignancy or with the history of malignancy 8. Patients induced in remission with biologics or cyteapheresis 9. Patients diagnosed not to be appropriate in entry by doctors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dissapearance rates of bloody stool on week 2
- Secondary Outcome Measures
Name Time Method